SavedAdd your journal

Journals / Eurasian Journal of Medical Investigation / 2019 / Cilt: 3 - Sayı: 1

Co-valuation of Red Cell Distribution Width Changes in Different Group of Familial Mediterranean Fever Patients Address for

Aslıhan Dilara DEMİR
Zeynep Hülya DURMAZ
Rıdvan GÜÇKAN
Çetin KILINÇ
Orhan DEMİR
Pages
41–45
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Blood RDW measurements were determined in both fmf and control groups.Results: We didn’t reach any statistical importance between healthy individuals and patients with heterozygous andhomozygous FMF.Conclusion: In our work, we didn’t consider rdw as a useful marker between groups which have different mutations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Our aim in this study is to evaluate the Red cell distrubition width (RDW) levels in individuals with FMF whorefer to our clinic and to investigate their usefulness as a prognostic factor.Methods: Participants of this work, who referred to our policlinics between January 2016 and January 2017, were recruitedthrough the patient database of our hospital.
📊
Key Findings & Data:The study included 86 patients.
💡
Conclusion & Impact:Blood RDW measurements were determined in both fmf and control groups.Results: We didn’t reach any statistical importance between healthy individuals and patients with heterozygous andhomozygous FMF.Conclusion: In our work, we didn’t consider rdw as a useful marker between groups which have different mutations.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Our aim in this study is to evaluate the Red cell distrubition width (RDW) levels in individuals with FMF whorefer to our clinic and to investigate their usefulness as a prognostic factor.Methods: Participants of this work, who referred to our policlinics between January 2016 and January 2017, were recruitedthrough the patient database of our hospital. The study included 86 patients. In the FMF group, there were totalof 56 patients (35 females, 21 males), and in the control group, there were 30 patients (19 females and 11 males). Therewere no clinical interventions. Blood RDW measurements were determined in both fmf and control groups.Results: We didn’t reach any statistical importance between healthy individuals and patients with heterozygous andhomozygous FMF.Conclusion: In our work, we didn’t consider rdw as a useful marker between groups which have different mutations.

🔖

Cite This Article

DEMİR, A. D., DURMAZ, Z. H., GÜÇKAN, R., KILINÇ, Ç., DEMİR, O. (2022). Co-valuation of Red Cell Distribution Width Changes in Different Group of Familial Mediterranean Fever Patients Address for. Eurasian Journal of Medical Investigation, Cilt: 3 - Sayı: 1, 41–45. https://ajindex.com/articles/508727

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Akar N, Misiroğlu M, Yalcinkaya F, Akar E, Cakar N, Tumer N, Akcakus M, Tastan H, Matzner Y. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mut 2000;15:118–9
  2. Yalcinkaya F, Tekin M, Çakar N, Akar E, Akar N, Tümer N. Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients. Q J Med 2000;93:681
  3. Gunel-Ozcan A, Sayin DB, Misirlioğlu ED, Güliter S, Yakaryilmaz F, Ensari C. The spectrum of FMF mutations and genotypes in the referrals to molecular genetic laboratory at Kirikkale University in Turkey. Mol Biol Rep 2009;36:757–60
  4. Köklü S, Oztürk MA, Balci M, Yüksel O, Ertenli I, Kiraz S. Interferon- gamma levels in familial Mediterranean fever. Joint Bone Spine 2005;72:38–40
  5. Peynircioğlu B, Yılmaz E. Ailevi akdeniz ateşi hastalığının moleküler temeli. Hacettepe Tıp Dergisi 2006;37:223–9
  6. Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006;45:746–50
  7. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med 1991;9:71–4
  8. Makhoul BF, Khourieh A, Kaplan M, et al. Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. Int J Cardiol 2013;167:1412–6
  9. Dabbah S, Hammerman H, Markiewicz W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 2010;105:312–7
  10. Baynes RD, Bothwell TH, Bezwoda WR, et al. Hematologic and iron-related measurements in rheumatoid arthritis. Am J Clin Pathol 1987;87:196–200
  11. Dada OA, Uche E, Akinbami A, Odesanya M, Olabode SJ, Adediran A. Therelationshipbetweenredbloodcelldistributionwidthandbloodpressure in patientswithtype 2 diabetesmellitus in Lagos, Nigeria. J Blood med 2014;5:185–9
  12. A. Nakamura, M. Matsuda, K.-I. Tazawa, Y. Shimojima, and S.- I. Ikeda, “Successful treatment with infliximab and low-dose methotrexate in a Japanese patient with familial Mediterranean fever,”Internal Medicine, vol. 46, supplement 15, pp. 1247–1249,2007
  13. Sönmez HE, Batu ED, Özen S. Familial Mediterranean fever: current perspectives. J Inflamm Res 2016;9:13–20
  14. Ozen S, Batu ED. The myths we believed in familial. Mediterranean fever: what have we learned in the past years? Semin Immunopathol 2015;37:363–9
  15. Padeh S, Berkun Y. Familial Medit